• Molecular NameBetamethasone
  • SynonymNA
  • Weight392.467
  • Drugbank_IDDB00443
  • ACS_NO378-44-9
  • Show 2D model
  • LogP (experiment)1.772
  • LogP (predicted, AB/LogP v2.0)1.99
  • pka8.4
  • LogD (pH=7, predicted)1.99
  • Solubility (experiment)0.0666 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-3.94
  • LogSw (predicted, AB/LogsW2.0)0.07
  • Sw (mg/ml) (predicted, ACD/Labs)0.04
  • No.of HBond Donors3
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds2
  • TPSA94.83
  • StatusFDA approved
  • Administrationoral or topical
  • PharmacologyA moderately potent glucocorticoid steroid with anti-inflammatory and immunosuppressive properties.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability72.0
  • Protein binding64.0
  • Volume of distribution (VD)1.32
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • Metabollsmhepatic CYP3A4
  • Half life5.6 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySymptoms of overdose include burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A